Real-World REKOVELLE study targets IVF success in asian women

NCT ID NCT06561958

Ongoing Knowledge-focused Sponsor: Ferring Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 1,500 Asian women using REKOVELLE for the first time during IVF to see how well it works in everyday medical practice. Researchers will track live birth rates and how the drug is used. The goal is to understand its real-world effectiveness and safety for this specific group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

REKOVELLE (a hormone drug for ovarian stimulation)

What this could lead to

If successful, this study could confirm that REKOVELLE is effective and safe for Asian women, potentially improving IVF success rates in this population.

What could go wrong

This is an observational study, not a controlled trial, so results may be influenced by other factors. It does not test a new treatment, only gathers real-world data.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infertility disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INFERTILITY

Contacts and locations

Show contact details

Locations

Ferring Investigational Site

Chiba, Chiba, 2610023, Japan
Ferring Investigational Site

Fukuoka, Fukuoka, 8120013, Japan
Ferring Investigational Site

Kitakyushu, Fukuoka, 8070825, Japan
Ferring Investigational Site

Takasaki, Gunma, 3700841, Japan
Ferring Investigational Site

Hiroshima, Hiroshima, 7320822, Japan
Ferring Investigational Site

Bunkyō City, Japan, 1130033, Japan
Ferring Investigational Site

Tokyo, Tokyo, 1600023, Japan
Ferring Investigational Site

Hiroshima, 7300035, Japan
Ferring Investigational Site

Hokkaido, 0600003, Japan
Ferring Investigational Site

Hyōgo, 6500021, Japan
Ferring Investigational Site

Osaka, 5300011, Japan
Ferring Investigational Site

Osaka, 5500015, Japan
Ferring Investigational Site

Saitama, 3540035, Japan
Ferring Investigational Site

Busan, Busan, 49241, South Korea
Ferring Investigational Site

Daegu, Daegu, 41910, South Korea
Ferring Investigational Site

Seongnam-si, Seongnam, 13496, South Korea
Ferring Investigational Site

Busan, 47245, South Korea
Ferring Investigational Site

Tainan, Tainan, 70403, Taiwan
Ferring Investigational Site

Tainan, Tainan, 71004, Taiwan
Ferring Investigational Site

Taoyuan, Taoyuan, 333, Taiwan
Ferring Investigational Site

Taichung, 406, Taiwan
Ferring Investigational Site

Taipei, 100225, Taiwan
Ferring Investigational Site

Taipei, 110, Taiwan
Ferring Investigational Site

Bangkok, 10700, Thailand
Ferring Investigational Site

Hanoi, Hanoi, 100000, Vietnam
Ferring Investigational Site

Ho Chi Minh City, Ho Chi Minh City, 700000, Vietnam
Ferring Investigational Site

Ho Chi Minh City, Ho Chi Minh City, Vietnam
Ferring Investigational Site

Huế, Huế, 49000, Vietnam
Maria Fertility Hospital

Seoul, 02586, South Korea
Naresuan University Hospital

Phitsanulok, Muang, 65000, Thailand
Ramathibodi Hospital

Bangkok, Ratchathewi, 10400, Thailand